A Trial to Evaluate Safety, Tolerability, and Efficacy of Orally Administered OPC-67683

Clinical trial NCT02573350 · COMPLETED

Trial details

NCT number: NCT02573350
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Tuberculosis, Multidrug-Resistant

Start date: 2009-03-26
Primary completion: 2011-10-27
Enrollment: 213

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.